Drug repurposing for new, efficient, broad spectrum antivirals
- PMID: 30794895
- PMCID: PMC7114681
- DOI: 10.1016/j.virusres.2019.02.011
Drug repurposing for new, efficient, broad spectrum antivirals
Abstract
Emerging viruses are a major threat to human health. Recent outbreaks have emphasized the urgent need for new antiviral treatments. For several pathogenic viruses, considerable efforts have focused on vaccine development. However, during epidemics infected individuals need to be treated urgently. High-throughput screening of clinically tested compounds provides a rapid means to identify undiscovered, antiviral functions for well-characterized therapeutics. Repurposed drugs can bypass part of the early cost and time needed for validation and authorization. In this review we describe recent efforts to find broad spectrum antivirals through drug repurposing. We have chosen several candidates and propose strategies to understand their mechanism of action and to determine how resistance to antivirals develops in infected cells.
Keywords: Antivirals; Drug repurposing; Virus.
Copyright © 2019 Elsevier B.V. All rights reserved.
Figures
Similar articles
-
Repurposing drugs targeting epidemic viruses.Drug Discov Today. 2022 Jul;27(7):1874-1894. doi: 10.1016/j.drudis.2022.04.008. Epub 2022 Apr 12. Drug Discov Today. 2022. PMID: 35427764 Review.
-
Drug Repurposing for Viral Infectious Diseases: How Far Are We?Trends Microbiol. 2018 Oct;26(10):865-876. doi: 10.1016/j.tim.2018.04.004. Epub 2018 May 11. Trends Microbiol. 2018. PMID: 29759926 Free PMC article. Review.
-
Strategy, Progress, and Challenges of Drug Repurposing for Efficient Antiviral Discovery.Front Pharmacol. 2021 May 4;12:660710. doi: 10.3389/fphar.2021.660710. eCollection 2021. Front Pharmacol. 2021. PMID: 34017257 Free PMC article. Review.
-
Antiviral activity of cationic amphiphilic drugs.Expert Rev Anti Infect Ther. 2017 May;15(5):483-492. doi: 10.1080/14787210.2017.1305888. Epub 2017 Mar 20. Expert Rev Anti Infect Ther. 2017. PMID: 28286997 Free PMC article. Review.
-
Repurposing Kinase Inhibitors as Antiviral Agents to Control Influenza A Virus Replication.Assay Drug Dev Technol. 2015 Dec;13(10):638-49. doi: 10.1089/adt.2015.0003.drrr. Epub 2015 Jul 20. Assay Drug Dev Technol. 2015. PMID: 26192013 Free PMC article.
Cited by
-
Cyclosporine and COVID-19: Risk or favorable?Am J Transplant. 2020 Nov;20(11):2975-2982. doi: 10.1111/ajt.16250. Epub 2020 Sep 7. Am J Transplant. 2020. PMID: 32777170 Free PMC article. Review.
-
Development of peptides targeting receptor binding site of the envelope glycoprotein to contain the West Nile virus infection.Sci Rep. 2021 Oct 11;11(1):20131. doi: 10.1038/s41598-021-99696-w. Sci Rep. 2021. PMID: 34635758 Free PMC article.
-
Recent advances on therapeutic potentials of gold and silver nanobiomaterials for human viral diseases.Curr Res Chem Biol. 2022;2:100021. doi: 10.1016/j.crchbi.2022.100021. Epub 2022 Feb 1. Curr Res Chem Biol. 2022. PMID: 35815068 Free PMC article. Review.
-
Old Weapon for New Enemy: Drug Repurposing for Treatment of Newly Emerging Viral Diseases.Virol Sin. 2020 Jun;35(3):253-255. doi: 10.1007/s12250-020-00204-7. Epub 2020 Feb 11. Virol Sin. 2020. PMID: 32048130 Free PMC article. No abstract available.
-
Therapeutic role of corticosteroids in COVID-19: a systematic review of registered clinical trials.Futur J Pharm Sci. 2021;7(1):67. doi: 10.1186/s43094-021-00217-3. Epub 2021 Mar 17. Futur J Pharm Sci. 2021. PMID: 33754123 Free PMC article. Review.
References
-
- Atkins M., Jones C.A., Kirkpatrick P. Sunitinib maleate. Nat. Rev. Drug Discov. 2006;5:279–280. - PubMed
-
- Baram-Pinto D., Shukla S., Perkas N., Gedanken A., Sarid R. Inhibition of herpes simplex virus type 1 infection by silver nanoparticles capped with mercaptoethane sulfonate. Bioconjug. Chem. 2009;20:1497–1502. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources